Case Report June 14, 2022

A Case and Proposed Mechanism of Catatonia During the Post-Acute Phase of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

; ; ; ; ; ; ; ; ; ; ; ; ;

Prim Care Companion CNS Disord 2022;24(3):21cr03233

  1. Gouse BM, Spears WE, Nieves Archibald A, et al. Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism. Brain Behav Immun. 2020;89:529–530. PubMed CrossRef
  2. Scheiner NS, Smith AK, Wohlleber M, et al. COVID-19 and catatonia: a case series and systematic review of existing literature. J Acad Consult Liaison Psychiatry. 2021;62(6):645–656. PubMed CrossRef
  3. Varatharaj A, Thomas N, Ellul MA, et al; CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. (Published correction appears in Lancet Psychiatry. July 14, 2020.) Lancet Psychiatry. 2020;7(10):875–882. PubMed CrossRef
  4. Bush G, Fink M, Petrides G, et al. Catatonia, I: rating scale and standardized examination. Acta Psychiatr Scand. 1996;93(2):129–136. PubMed CrossRef
  5. Caan MP, Lim CT, Howard M. A case of catatonia in a man with COVID-19. Psychosomatics. 2020;61(5):556–560. PubMed CrossRef
  6. Deocleciano de Araujo C, Schlittler LXC, Sguario RM, et al. Life-threatening catatonia associated with coronavirus disease 2019. J Acad Consult Liaison Psychiatry. 2021;62(2):256–257. PubMed CrossRef
  7. Vazquez-Guevara D, Badial-Ochoa S, Caceres-Rajo KM, et al. Catatonic syndrome as the presentation of encephalitis in association with COVID-19. BMJ Case Rep. 2021;14(6):e240550. PubMed CrossRef
  8. Fiaschè F, Adriani B, Mancinelli I, et al. Treatment of catatonia with asenapine in a patient with schizotypal personality disorder, psychotic depression and septic shock from SARS-CoV-2: a case report. CNS Neurol Disord Drug Targets. 2021;20(5):473–477. PubMed CrossRef
  9. Zain SM, Muthukanagaraj P, Rahman N. Excited catatonia: a delayed neuropsychiatric complication of COVID-19 infection. Cureus. 2021;13(3):e13891. PubMed CrossRef
  10. Torrico T, Kiong T, D’Assumpcao C, et al. Postinfectious COVID-19 catatonia: a report of two cases. Front Psychiatry. 2021;12:696347. PubMed CrossRef
  11. Mulder J, Feresiadou A, Fällmar D, et al. Autoimmune encephalitis presenting with malignant catatonia in a 40-year-old male patient with COVID-19. Am J Psychiatry. 2021;178(6):485–489. PubMed CrossRef
  12. Zandifar A, Badrfam R. Exacerbation of psychosis accompanied by seizure and catatonia in a patient with COVID-19: a case report. Psychiatry Clin Neurosci. 2021;75(2):63–64. PubMed CrossRef
  13. Amouri J, Andrews PS, Heckers S, et al. A case of concurrent delirium and catatonia in a woman with coronavirus disease 2019. J Acad Consult Liaison Psychiatry. 2021;62(1):109–114. PubMed CrossRef
  14. Austgen G, Meyers MS, Gordon M, et al. The use of electroconvulsive therapy in neuropsychiatric complications of coronavirus disease 2019: a systematic literature review and case report. J Acad Consult Liaison Psychiatry. 2022;63(1):86–93. PubMed CrossRef
  15. Kwon HJ, Patel KH, Ramirez M, et al. A case of fatal catatonia in a COVID-19 patient. Cureus. 2021;13(7):e16529. PubMed CrossRef
  16. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22. PubMed CrossRef
  17. Nalleballe K, Reddy Onteddu S, Sharma R, et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun. 2020;88:71–74. PubMed CrossRef
  18. Nezgovorova V, Ferretti CJ, Pallanti S, et al. Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. J Psychiatr Res. 2022;149:367–373. PubMed CrossRef
  19. Fusunyan M, Praschan N, Fricchione G, et al. Akinetic mutism and coronavirus disease 2019: a narrative review. J Acad Consult Liaison Psychiatry. 2021;62(6):625–633. PubMed CrossRef
  20. Zhou Z, Kang H, Li S, et al. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179–2184. PubMed CrossRef
  21. Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78(6):682–683. PubMed CrossRef
  22. Gubernatorova EO, Gorshkova EA, Polinova AI, et al. IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020;53:13–24. PubMed CrossRef
  23. Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168–175. PubMed CrossRef
  24. Rustad JK, Landsman HS, Ivkovic A, et al. Catatonia: an approach to diagnosis and treatment. Prim Care Companion CNS Disord. 2018;20(1):17f02202. PubMed CrossRef
  25. Bartolommei N, Lattanzi L, Callari A, et al. Catatonia: a critical review and therapeutic recommendations. J Psychopathology. 2012;18:234–246.